Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001884 · ClinicalTrials.gov registry record

Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis

A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status

NCT00001884: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

NCT00001884 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001884 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status

Study Summary

Pulmonary fibrosis (PF) is a condition in which the lungs of a patient become scarred and fibrous. It has been known to occur in as many as 40% of patients diagnosed with rheumatoid arthritis (RA). The cause of the pulmonary fibrosis in patients with RA is unknown. Researchers hope to improve their understanding of the disease process involved in PF and RA by analyzing specimens collected by bronchoscopy, lung biopsy, lung transplantation, or autopsy from patients with these conditions. The purpose of this study is to collect specimens from rheumatoid arthritis patients with and without pulmonary fibrosis as well as patients with pulmonary fibrosis without associated diseases or cause (idiopathic pulmonary fibrosis).

Trial Details

FieldValue
Start Date 1999-03-21
Est. Completion 2007-12-28

What the finished NCT00001884 record still lists

NCT00001884 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 0 interventions.

NCT00001884 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00001884 about?

NCT00001884 is a clinical study titled "Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis". Pulmonary fibrosis (PF) is a condition in which the lungs of a patient become scarred and fibrous. It has been known to occur in as many as 40% of patients diagnosed with rheumatoid arthritis (RA). The cause of the pulmonary fibrosis in patients with RA is unknown. Researchers hope to improve their...

What is the current status of trial NCT00001884?

This trial is currently completed. The study started on 1999-03-21. Estimated completion is 2007-12-28.

Who is sponsoring clinical trial NCT00001884?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00001884, the US trial registry maintained by the National Library of Medicine. NCT00001884 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.